Relias Media - Continuing Medical Education Publishing

The trusted source for

healthcare information and

CONTINUING EDUCATION.

  • Sign In
  • Sign Out
  • MyAHC
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • Subscribe Now
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    Home » Blogs » ED Push » High-sensitivity Test for Cardiac Troponin Safe, Effective for ED Use

    ED Push
    ED Push RSS FeedRSS

    edpush-webheader-rm

    Free Monthly News from the Award Winning Publisher of:

    • Emergency Medicine Reports
    • Trauma Reports
    • Critical Care Alert
    • ED Management
    • ED Legal Letter
    • Pediatric Emergency Medicine Reports
    • EM Reports' Study Guide 2018
    • STROKE: The Cutting Edge: 2017
    • Pediatric Trauma 2018
    • STEMI Watch 2018
     

     

    High-sensitivity Test for Cardiac Troponin Safe, Effective for ED Use

    August 22, 2018
    No Comments
    Reprints
    Facebook Twitter Linkedin Share Share
    By Brenda Mooney

    If it hasn’t happened already, how your ED rules out myocardial infarction (MI) in chest pain patients is likely to change dramatically.

    In a new report, researchers have deemed the high-sensitivity blood test for cardiac troponin safe and effective for use in EDs. The key advantage was that clinicians had the results much more quickly than conventional methods. Researchers developed a procedure for assessing the results of the new test, comparing it to a conventional troponin test, which takes three hours to complete.

    The team conducted an observational study of 536 patients at the Parkland Health and Hospital System ED who were undergoing MI rule-out between August and October 2017. Sixty percent of patients presented with chest pain, 16% complained of shortness of breath, and 24% offered other complaints. No one exhibited ST elevations on ECG.

    Participants were classified into two groups: “ruled out” or “abnormal,” based on high-sensitivity troponin test levels and change values. Researchers reported that the new procedure ruled out 30% of patients immediately and an additional 25% at one hour. By three hours high-sensitivity troponin tests ruled out heart attack in 83.8% of patients vs. 80.4% using the conventional test.

    The authors concluded that the “early rule-out protocol appears safe, with a sensitivity and negative predictive value of 100%.”

    For more information about this test and its application in the ED, be sure to read about it in the June 2018 issue of ED Management.

     


    Live Training - Blue

    ED and Outpatient Services: CoPs and Proposed Changes

    This two-part webinar series will cover the CMS Emergency Department and Outpatient CoPs and proposed changes. The first part will review CoPs requirements ED staff must know: EMTALA, restraint and seclusion, grievances, fundamental protocols, staffing, provision of services both on and off-campus, standards of care, medical director, and policies and procedures.

    Find Out More - Red


     

    Post a comment to this article

    Report Abusive Comment

    www.reliasmedia.com

    ED Push

    View PDF
    ED Push - Sept 2018 Issue
    September 1, 2018

    Table Of Contents

    High-sensitivity Test for Cardiac Troponin Safe, Effective for ED Use

    What’s the Root of ED Medical Errors?

    Deciding Between Oral Therapy and IV Antibiotics in Skin Infections

    Investigators Explore Evolving Causes of Anaphylaxis

    Shop Now: Search Products

    • Subscription Publications
    • Books & Study Guides
    • Webinars
    • Group & Site
      Licenses
    • State CME/CE
      Requirements

    Webinars And Events

    View All Events
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • Subscribe Now
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    • Help
    • Search
    • About Us
    • Sign In
    • Register
    Relias Media - Continuing Medical Education Publishing

    The trusted source for

    healthcare information and

    CONTINUING EDUCATION.

    Customer Service

    customerservice@reliasmedia.com

    U.S. and Canada: 1-800-688-2421

    International +1-404-262-5476

    Accounts Receivable

    1-800-370-9210
    ReliasMedia_AR@reliasmedia.com

    Mailing Address

    • 1010 Sync St., Suite 100
      Morrisville, NC 27560-5468
      USA

    © 2020 Relias. All rights reserved.

    Do Not Sell My Personal Information  Privacy Policy  Terms of Use  Contact Us  Reprints  Group Sales

    For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com

    Design, CMS, Hosting & Web Development :: ePublishing